<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Aurigene Discovery Technologies Limited from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Aurigene Discovery Technologies Limited news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 13:09:43 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Aurigene+Discovery+Technologies+Limited" rel="self" type="application/rss+xml" />

	
<item><title>Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Research 2/5/10</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036664&amp;HITNO=0&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036664&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536699449%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036664&amp;HITNO=0&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036664&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536699449%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>American Pharmaceutical Outsourcing:</description></item>
<item><title>Research and Markets: The Contract Research Market for Drug Discovery Technologies: Opportunities for Life Science Suppliers</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032204&amp;HITNO=1&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032204&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534544615%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032204&amp;HITNO=1&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032204&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534544615%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Yahoo! Canada:</description></item>
<item><title>Aastra to Hold Conference Call Following Announcement of Fourth Quarter 2009 Financial Results</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037364&amp;HITNO=2&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037364&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537045911%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037364&amp;HITNO=2&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037364&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537045911%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Genetic Engineering News:</description></item>
<item><title>Research and Markets: The Contract Research Market for Drug Discovery Technologies: Opportunities for Life Science Suppliers</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029679&amp;HITNO=3&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029679&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533230822%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029679&amp;HITNO=3&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029679&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533230822%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Your Story:</description></item>
<item><title>Research and Markets: The Contract Research Market for Drug Discovery Technologies: Opportunities for Life Science Suppliers</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029386&amp;HITNO=4&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029386&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533119578%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029386&amp;HITNO=4&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029386&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533119578%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>TradingMarkets:</description></item>
<item><title>Research and Markets: The Contract Research Market for Drug Discovery Technologies: Opportunities for Life Science Suppliers</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029759&amp;HITNO=5&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029759&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533257502%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029759&amp;HITNO=5&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029759&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533257502%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Earthtimes.org:</description></item>
<item><title>Research and Markets: The Contract Research Market for Drug Discovery Technologies: Opportunities for Life Science Suppliers</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029739&amp;HITNO=6&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029739&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533248830%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029739&amp;HITNO=6&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029739&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533248830%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
<item><title>Research and Markets: The Contract Research Market for Drug Discovery Technologies: Opportunities for Life Science Suppliers</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029680&amp;HITNO=7&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029680&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533231195%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029680&amp;HITNO=7&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029680&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533231195%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Business Wire via Yahoo!:</description></item>
<item><title>Research and Markets: The Contract Research Market for Drug Discovery Technologies: Opportunities for Life Science Suppliers</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029237&amp;HITNO=8&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029237&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533046007%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029237&amp;HITNO=8&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029237&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533046007%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Individual.com:</description></item>
<item><title>Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Research</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4025351&amp;HITNO=9&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4025351&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2529679762%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4025351&amp;HITNO=9&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4025351&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2529679762%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Financials.com:</description></item>
<item><title>Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Research</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4023389&amp;HITNO=10&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4023389&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2528196154%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4023389&amp;HITNO=10&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4023389&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2528196154%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>Infosys Technologies And Elan Pharmaceuticals Apply Co-Creation Model To Transform Discovery Research</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4019619&amp;HITNO=11&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4019619&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2526400715%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4019619&amp;HITNO=11&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4019619&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2526400715%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharmaceutical Online:</description></item>
<item><title>Infosys Technologies And Elan Pharmaceuticals Apply Co-Creation Model To Transform Discovery Research</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4019510&amp;HITNO=12&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4019510&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2526339838%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4019510&amp;HITNO=12&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4019510&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2526339838%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Drug Discovery Online:</description></item>
<item><title>Infosys Technologies And Elan Pharmaceuticals Apply Co-Creation Model To Transform Discovery Research</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4019562&amp;HITNO=13&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4019562&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2526370041%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4019562&amp;HITNO=13&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4019562&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2526370041%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Bioresearch Online:</description></item>
<item><title>Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Research</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4018442&amp;HITNO=14&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4018442&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525679460%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4018442&amp;HITNO=14&amp;MSIZE=222&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Aurigene%20Discovery%20Technologies%20Limited&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4018442&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525679460%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>CNW Telbec:</description></item>
</channel></rss>